CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net income	$ 216,998	$ 137,828
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	15,024	13,182
Equity in income of unconsolidated entities, net	(156)	(269)
Amortization of stock-based compensation	15,619	8,023
Charges for impairments and lot option abandonments	1,370	12,478
Gain on increase in carrying amount of investment	(3,495)	0
Changes in assets and liabilities:
Real estate inventories	(127,199)	(29,452)
Mortgage loans held for sale	(32,936)	0
Receivables	112,999	52,315
Other assets	(5,688)	2,783
Accounts payable	(7,423)	16,062
Accrued expenses and other liabilities	(17,219)	(15,216)
Net cash provided by operating activities	167,894	197,734
Cash flows from investing activities:
Purchases of property and equipment	(12,547)	(12,445)
Proceeds from investment	717	0
Net investments in unconsolidated entities	(19,869)	(8,343)
Distributions from unconsolidated entities	16,289	0
Net cash used in investing activities	(15,410)	(20,788)
Cash flows from financing activities:
Borrowings from loans payable	420	0
Repayment of loans payable and senior notes	(454,828)	0
Borrowings on mortgage repurchase facilities	68,963	0
Repayments on mortgage repurchase facilities	(36,867)	0
Distributions to noncontrolling interests	(3,877)	(5,795)
Proceeds from issuance of common stock under share-based awards	1,041	518
Tax withholding paid on behalf of employees for share-based awards	(16,604)	(9,796)
Share repurchases, excluding excise tax	(86,745)	(69,970)
Net cash used in financing activities	(528,497)	(85,043)
Net (decrease) increase in cash and cash equivalents	(376,013)	91,903
Cash and cash equivalents–beginning of period	868,953	889,664
Cash and cash equivalents–end of period	$ 492,940	$ 981,567